改进尼古丁疫苗的新策略使用结构受约束的 hapten
Michael M Meijler1, Masayuki Matsushita, Laurence J Altobell
1Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Journal of the American Chemical Society
|June 12, 2003
概括
与灵活的类似物相比,合成受约束的尼古丁类似物并将其与KLH合,在小鼠中显著提高了抗体的产生和亲和力. 这为开发更有效的尼古丁相关免疫疗法提供了有希望的途径.
科学领域:
- 药用化学 医学化学
- 免疫学 免疫学 免疫学
- 药物开发 药物开发
背景情况:
- 尼古丁 (C10H14N2) 是一种具有显著上性质的精神活性类化合物.
- 开发有效的尼古丁成免疫疗法需要有力的和特定的抗体反应.
- 之前的研究使用了柔性尼古丁哈普,产生了有限的免疫性.
研究的目的:
- 为了合成新的受约束的尼古丁类似物.
- 与灵活的相比,评估这些受约束类型的免疫潜力.
- 评估由此产生的抗体标位和对尼古丁的亲和力.
主要方法:
- 合成受约束的尼古丁类似物.
- 类似于钥匙孔子血红素 (KLH) 载体蛋白质的类型的结合.
- 用哈载体结合体对小鼠进行免疫接种.
- 使用已建立的免疫试验测量抗体标位和亲和力.
主要成果:
- 限制性尼古丁模拟合物在免疫小鼠中引起了显著更高的抗体标位.
- 产生的抗体与柔性基联体的抗体相比,对尼古丁的亲和力增加.
- KLH结合证明有效地提高了尼古丁 haptens 的免疫性.
结论:
- 限制性尼古丁类似物是产生高滴度,高亲和度的抗尼古丁抗体的优越策略.
- 这种方法有可能开发针对尼古丁成的新型免疫疗法.
- 哈普顿的结构刚性是引起强大的免疫反应的关键因素.
更多相关视频
相关概念视频
Chromatin Immunoprecipitation- ChIP
Chromatin immunoprecipitation, or ChIP, is an antibody-based technique used to identify sites on DNA that bind to transcription factors of interest or histone proteins. It also helps determine the type of histone modifications such as acetylation, phosphorylation, or methylation.
Types of ChIP
ChIP can be divided into two types - X-ChIP and N-ChIP. X-ChIP involves in vivo cross-linking of histones and regulatory proteins to DNA, fragmenting the DNA by sonication, and isolating the protein-DNA...
Types of ChIP
ChIP can be divided into two types - X-ChIP and N-ChIP. X-ChIP involves in vivo cross-linking of histones and regulatory proteins to DNA, fragmenting the DNA by sonication, and isolating the protein-DNA...
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
iChip
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...


